Oral Cancer News and Research

RSS
Oral cancer is the sixth most common type of cancer worldwide and in the U.S., one person dies every hour from the disease. According to American Cancer Society data, nearly as many women will be diagnosed with oral cancer as with cervical cancer this year. The key to reducing the impact of this disease is early detection.
New oral cancer drugs getting more expensive over time, study shows

New oral cancer drugs getting more expensive over time, study shows

Study sheds light on role of RNA editing in cancer

Study sheds light on role of RNA editing in cancer

Molecular basis for tongue cancer progression: an interview with Dr Simona Principe

Molecular basis for tongue cancer progression: an interview with Dr Simona Principe

This No Smoking Day think of your oral health and kick the habit

This No Smoking Day think of your oral health and kick the habit

Scientists identify potential marker for recurring HPV-positive oropharyngeal cancer

Scientists identify potential marker for recurring HPV-positive oropharyngeal cancer

Researchers partner to help personalize cancer care

Researchers partner to help personalize cancer care

New tool could help identify patients most likely to benefit from chemoprevention

New tool could help identify patients most likely to benefit from chemoprevention

Research sheds new light on the fight against tonsil cancer

Research sheds new light on the fight against tonsil cancer

UF Health researcher reveals how betel nut's psychoactive chemical works in the brain

UF Health researcher reveals how betel nut's psychoactive chemical works in the brain

Study: High school athletes use smokeless tobacco at a higher rate compared to non-athletes

Study: High school athletes use smokeless tobacco at a higher rate compared to non-athletes

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

Researcher reveals link between inflammatory response of neutrophils and spread of oral cancer

Patients with HPV traces post-treatment more likely to have oropharyngeal cancer recurrence

Patients with HPV traces post-treatment more likely to have oropharyngeal cancer recurrence

Taiho, Servier sign exclusive license agreement to develop and commercialize TAS-102 drug

Taiho, Servier sign exclusive license agreement to develop and commercialize TAS-102 drug

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Penn researchers to present clinical data at 2015 ASCO Annual Meeting

Penn researchers to present clinical data at 2015 ASCO Annual Meeting

OSU researchers find promising approach to treating epithelial cancer

OSU researchers find promising approach to treating epithelial cancer

Oral, Head & Neck Cancer Awareness Week: Mount Sinai experts to share tips on cancer prevention

Oral, Head & Neck Cancer Awareness Week: Mount Sinai experts to share tips on cancer prevention

Dental experts join Oral Cancer Foundation to raise awareness about oral cancer

Dental experts join Oral Cancer Foundation to raise awareness about oral cancer

Study: Green tea compound may activate a cycle that kills oral cancer cells

Study: Green tea compound may activate a cycle that kills oral cancer cells

TOSH Program aims to improve oral-systemic health

TOSH Program aims to improve oral-systemic health